Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Mika, Joanna ^a   Popiolek Barczyk, Katarzyna ^a   Rojewska, Ewelina ^a   Makuch, Wioletta ^a   Starowicz, Katarzyna ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN II; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MINOCYCLINE; MORPHINE; MU OPIATE RECEPTOR; UNCLASSIFIED DRUG; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ANTIINFECTIVE AGENT; NARCOTIC ANALGESIC AGENT;

ALLODYNIA; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIALLODYNIC EFFECT; ANTIHYPERALGESIC EFFECT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; HYPERALGESIA; IMMUNOCYTOCHEMISTRY; LOW DRUG DOSE; MALE; MICROGLIA; MORNING DOSAGE; NERVE CELL STIMULATION; NERVE COMPRESSION; NERVE INJURY; NEUROIMMUNOLOGY; NEUROPATHIC PAIN; NONHUMAN; RAT; RECEPTOR DOWN REGULATION; REPEATED DRUG DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE INJURY; SPINAL CORD; SPINAL GANGLION; WESTERN BLOTTING; AGONISTS; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEURALGIA; WISTAR RAT;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, OPIOID; ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GENE EXPRESSION REGULATION; MALE; MICROGLIA; MINOCYCLINE; MORPHINE; NEURALGIA; RATS, WISTAR; RECEPTORS, OPIOID, DELTA;

EID: 84905643984     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104420     Document Type: Article

References (108)

1. Hirsch SJ, Dickenson AH (2014) Morphine sensitivity of spinal neurons in the chronic constriction injury neuropathic rat pain model. Neurosci Lett 562: 97-101.
2. Przewlocki R, Przewlocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429:79-91. (Pubitemid 33043984)
3. Przewlocki R, Przewlocka B (2005) Opioids in neuropathic pain. Curr Pharm Des 11: 3013-3025. (Pubitemid 41158089)
4. Eisenberg E, McNicol ED, Carr DB (2005) Efficacy and safety of opioid agonists in the treatment of neuropathic pain of non- malignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA; 293:3043-3052. (Pubitemid 40965075)
5. McQuay HJ (2002) Neuropathic pain: evidence matters. Eur J Pain.;6:11-8.
6. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH (1992) Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955.
7. Kieffer BL, Befort K, Gavériaux-Ruff C, Hirth CG (1992) The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A 89: 12048-12052. (Pubitemid 23004782)
8. Chen Y, Mestek A, Liu J, Yu L (1993) Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J 295: 625-628. (Pubitemid 23323479)
9. Minami M, Hosoi Y, Toya T, Katao Y, Maekawa K, et al. (1993) In situ hybridization study of kappa-opioid receptor mRNA in the rat brain. Neurosci Lett 162: 161-164. (Pubitemid 23347971)
10. George SR, Fan T, Xie Z, Tse R, Tam V, et al. (2000) Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275: 26128-26135.
11. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, et al. (2000) Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20: RC110.
12. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, et al. (2004) A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci USA 101: 5135-5139. (Pubitemid 38469214)
13. Mika J, Przewlocki R, Przewłocka B (2001) The role of delta-opioid receptor subtypes in neuropathic pain. Eur J Pharmacol 415: 31-37. (Pubitemid 32197616)
14. Nozaki C, Le Bourdonnec B, Reiss D, Windh RT, Little PJ, et al. (2012) δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization. J Pharmacol Exp Ther 342: 799-807.
15. Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, et al. (2009) Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain. Pain 141: 283-291.
16. Gavériaux-Ruff C, Kieffer BL (2011) Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav Pharmacol 22: 405-414.
17. Fenalti G, Giguere PM, Katritch V, Huang XP, Thompson AA, et al. (2014) Molecular control of δ-opioid receptor signalling. Nature 506: 191-196.
18. Somvanshi RK, Kumar U (2014) δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling. PLoS One 9: e85193.
19. Lee YW, Chaplan SR, Yaksh TL (1995) Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 199: 111-114.
20. Steele AD, Szabo I, Bednar F, Rogers TJ (2002) Interactions between opioid and chemokine receptors: heterologous desensitization. Cytokine Growth Factor Rev 13: 209-222. (Pubitemid 34693175)
21. Osikowicz M, Mika J, Przewlocka B (2013) The glutamatergic system as a target for neuropathic pain relief. Exp Physiol 98: 372-384.
22. Cui Y, Liao XX, Liu W (2008) A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun 22: 114-123. (Pubitemid 350216368)
23. Makuch W, Mika J, Rojewska E, Zychowska M, Przewlocka B (2013) Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats. Neuropharmacology 75: 445-447.
24. Mika J, Rojewska E, Makuch W, Przewlocka B (2010) Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience 165: 1420-1428.
25. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B (2013) Importance of glial activation in neuropathic pain. Eur J Pharmacol 716: 106-119.
26. Watkins LR, Maier SF (2003) Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2: 973-985. (Pubitemid 37540579)
27. Wieseler-Frank J, Maier SF, Watkins LR (2005) Central proinflammatory cytokines and pain enhancement. Neurosignals 14: 166-174. (Pubitemid 41417105)
28. Amin AR, Attur MG, Thakker GD (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93: 14014-14019. (Pubitemid 26424237)
29. Colovic M, Caccia S (2003) Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat. Life Sci 791: 337-343. (Pubitemid 36638766)
30. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, et al. (2005) Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115: 71-83.
31. Pinkernelle J, Fansa H, Ebmeyer U, Keilhoff G (2013) Prolonged minocycline treatment impairs motor neuronal survival and glial function in organotypic rat spinal cord cultures. PLoS One 8: e73422.
32. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2508.
33. Niimi N, Kohyama K, Matsumoto Y (2013) Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases. Neuropathology 33: 612-616.
34. Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, et al. (2006) Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 7: 56.
35. Liu X, Su H, Chu TH, Guo A, Wu W (2013) Minocycline inhibited the proapoptotic effect of microglia on neural progenitor cells and protected their neuronal differentiation in vitro. Neurosci Lett 542: 30-36.
36. Garcia-Martinez EM, Sanz-Blasco S, Karachitos A, Bandez MJ, Fernandez-Gomez FJ, et al. (2010) Mitochondria and calcium flux as targets of neuroprotection caused by minocycline in cerebellar granule cells. Biochem Pharmacol 79: 239-250.
37. Kim TH, Kim HI, Kim J, Park M, Song JH (2011) Effects of minocycline on Na+ currents in rat dorsal root ganglion neurons. Brain Res 1370: 34-42.
38. Jin SX, Zhuang ZY, Woolf CJ, Ji RR (2003) p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23: 4017-4022. (Pubitemid 36958419)
39. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, et al. (2006) A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26: 3551-3560.
40. Chang YW, Waxman SG (2010) Minocycline attenuates mechanical allodynia and central sensitization following peripheral second-degree burn injury. J Pain 11: 1146-1154.
41. Hains BC, Waxman SG (2006) Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26: 4308-4317. (Pubitemid 44315390)
42. Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, et al. (2005) Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 22: 2431-2440. (Pubitemid 41758986)
43. Radad K, Moldzio R, Rausch WD (2010) Minocycline protects dopaminergic neurons against long-term rotenone toxicity. Can J Neurol Sci 37: 81-85
44. González JC, Egea J, Del Carmen Godino M, Fernandez-Gomez FJ, Sánchez-Prieto J, et al. (2007) Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca(2+) signalling in hippocampal neurons. Eur J Neurosci 26: 2481-2495. (Pubitemid 350050444)
45. Mika J, Osikowicz M, Makuch W, Przewlocka B (2007) Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 560: 142-149. (Pubitemid 46341303)
46. Mika J, Wawrzczak-Bargiela A, OsikowiczM, Makuch W, Przewlocka B (2009) Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice. Brain Behav Immun 23: 75-84.
47. Zychowska M, Rojewska E, Kreiner G, Nalepa I, Przewlocka B, et al. (2013) Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy. J Neuroimmunol 262: 35-45.
48. Filipovic R, Zecevic N (2008) Neuroprotective role of minocycline in co-cultures of human fetal neurons and microglia. Exp Neurol 211: 41-51.
49. Kobayashi K, Imagama S, Ohgomori T, Hirano K, Uchimura K, et al. (2013) Minocycline selectively inhibits M1 polarization of microglia. Cell Death Dis 4: e525.
50. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.
51. Bennett GJ, Xie Y (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.
52. Osikowicz M, Mika J, Makuch W, Przewlocka B (2008) Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 139: 117-126.
53. Yaksh TL, Rudy TA (1976) Chronic catheterization of the spinal subarachnoid space. Physiol. Behav 17: 1031-10.
54. Zawadzka M, Kaminska B (2005) A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells. Glia 49: 36-51. (Pubitemid 40023651)
55. Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, et al. (2014) The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J Mol Med (Berl) 92: 239-254.
56. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. (Pubitemid 17064313)
57. Mika J, Obara I, Przewlocka B (2011) The role of nociceptin and dynorphin in chronic pain: implications of neuro-glial interaction. Neuropeptides 45: 247-261.
58. Kerros C, Brood I, Sola B, Jauzac P, Allouche S (2010) Reduction of cell proliferation and potentiation of Fas-induced apoptosis by the selective kappa-opioid receptor agonist U50 488 in the multiple myeloma LP-1 cells. J Neuroimmunol 220: 69-78.
59. Abcam website. Available: http://www.abcam.com/delta-opioid-receptor- antibody-ab66317.html. Accessed 2014 May 20.
60. Neuromics website. Available: http://www.neuromics.com/ittrium/visit/ A1x66x1y1x85b1x1x9cy1x6217x1x96y1x4fax1x82y1x510x1x7f. Accessed 2014 May 20.
61. Mansson E, Bare L, Yang D (1994) Isolation of a human kappa opioid receptor cDNA from placenta. Biochem Biophys Res Commun 202: 1431-1437. (Pubitemid 24265928)
62. Ko JL, Arvidsson U, Williams FG, Law PY, Elde R, et al. (1999) Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. Brain Res Mol Brain Res 69: 171-185. (Pubitemid 29253810)
63. Mayer DJ, Mao J, Holt J, Price DD (1999) Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 96: 7731-7736. (Pubitemid 29328349)
64. Ossipov MH, Lopez Y, Nichols ML, Bian D, Porreca F (1995) The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci Lett 199: 87-90.
65. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, et al. (2003) Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 13: 1223-1232. (Pubitemid 36359298)
66. Gilron I, Bailey JM, Dongsheng Tu ME, Holden RR, et al. (2005) Morphine, Gabapentin, or Their Combination for Neuropathic Pain. N Engl J Med 13: 1324-1334. (Pubitemid 40411499)
67. Przewlocka B, Mika J, Labuz D, Toth G, Przewlocki R (1999) Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol 367: 189-196. (Pubitemid 29106370)
68. Kabli N, Cahill CM (2007) Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127: 84-93. (Pubitemid 44959432)
69. Porreca F, Tang QB, Bian D, Riedl M, Elde R, et al. (1998) Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 795: 197-203. (Pubitemid 28337831)
70. Stone LS, Vulchanova L, Riedl MS, Williams FG, Wilcox GL, et al. (2004) Effects of peripheral nerve injury on delta opioid receptor (DOR) immunoreactivity in the rat spinal cord. Neurosci Lett 361: 208-211. (Pubitemid 38609253)
71. Herradon G, Ezquerra L, Nguyen T, Wang C, Siso A, et al. (2008) Noradrenergic and opioidergic alterations in neuropathy in different rat strains. Neurosci Lett 438: 186-189.
72. Pol O, Murtra P, Caracuel L, Valverde O, Puig MM, et al. (2006) Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain. Neuropharmacology 50: 123-132. (Pubitemid 43069778)
73. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA (2003) Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104: 655-664. (Pubitemid 37289065)
74. Raghavendra V, Rutkowski MD, DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22: 9980-9989. (Pubitemid 35332883)
75. Mika J, Korostynski M, Kaminska D, Wawrzczak-Bargiela A, Osikowicz M, et al. (2008) Interleukin-1alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 13: 587-597.
76. Cunningham CL, Martínez-Cerdeño V, Noctor SC (2013) Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J Neurosci 33: 4216-4233.
77. Quock RM, Burkey TH, Varga E, Hosohata Y, Hosohata K, et al. (1999) The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol Rev 51: 503-532. (Pubitemid 29420213)
78. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, et al. (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137: 1148-1159.
79. Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM (2002) Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J Pharmacol Exp Ther 302: 1146-1150. (Pubitemid 34920237)
80. Holdridge SV, Cahill CM (2007a) Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11: 685-693. (Pubitemid 46830764)
81. Holdridge SV, Armstrong SA, Taylor AM, Cahill CM (2007b) Behavioural and morphological evidence for the involvement of glial cell activation in delta opioid receptor function: implications for the development of opioid tolerance. Mol Pain 3: 7.
82. Chang AC, Chao CC, Takemori AE, Gekker G, Hu S, et al. (1996) Arylacetamide-derived fluorescent probes: synthesis, biological evaluation, and direct fluorescent labeling of kappa opioid receptors in mouse microglial cells. J Med Chem 39: 1729-1735.
83. El-Hage N, Dever SM, Podhaizer EM, Arnatt CK, Zhang Y, et al. (2013) A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia. AIDS 27: 2181-2190.
84. Merighi S, Gessi S, Varani K, Fazzi D, Stefanelli A, et al. (2013) Morphine mediates a proinflammatory phenotype via m-opioid receptor-PKCε- Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol 86: 487-496.
85. Chao CC, Gekker G, Hu S, Sheng WS, Shark KB, et al. (1996) Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc Natl Acad Sci U S A 93: 8051-8056. (Pubitemid 26277163)
86. Chao CC, Hu S, Shark KB, Sheng WS, Gekker G, et al. (1997) Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther 281: 998-1004. (Pubitemid 27203837)
87. Turchan-Cholewo J, Dimayuga FO, Ding Q, Keller JN, Hauser KF, et al. (2008) Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res 86: 2100-2110.
88. Thorlin T, Persson PA, Eriksson PS, Hansson E, Rönnbäck L (1999) Delta-opioid receptor immunoreactivity on astrocytes is upregulated during mitosis. Glia 25: 370-378. (Pubitemid 29083836)
89. Scherrer G, Tryoen-Tóth P, Filliol D, Matifas A, Laustriat D, et al. (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103: 9691-9696. (Pubitemid 43955886)
90. Commons KG, Milner TA (1996) Cellular and subcellular localization of delta opioid receptor immunoreactivity in the rat dentate gyrus. Brain Res 738: 181-195. (Pubitemid 26378911)
91. Cheng PY, Liu-Chen LY, Pickel VM (1997) Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res 778: 367-380. (Pubitemid 28037417)
92. Horvath RJ, DeLeo JA (2009) Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci 29: 998-1005.
93. Kieffer BL, Gavériaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306. (Pubitemid 34518287)
94. Gavériaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL (2008) Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 27: 2558-2567. (Pubitemid 351781665)
95. Nadal X, Baños JE, Kieffer BL, Maldonado R (2006) Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci 23: 830-834.
96. Gallantine EL, Meert TF (2005) A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80. Basic Clin Pharmacol Toxicol 97: 39-51. (Pubitemid 40903094)
97. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A (2003) Upregulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101: 199-208. (Pubitemid 36044668)
98. Fraser GL, Gaudreau GA, Clarke PB, Ménard DP, Perkins MN (2000) Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation. Br J Pharmacol 129: 1668-1672. (Pubitemid 30219009)
99. Hurley RW, Hammond DL (2000) The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20: 1249-1259. (Pubitemid 30220481)
100. Happel C, Steele AD, Finley MJ, Kutzler MA, Rogers TJ (2008) DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-beta1. J Leukoc Biol 83: 956-963. (Pubitemid 351959876)
101. Szabo I, Chen XH, Xin L, Adler MW, Howard OM, et al. (2002) Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A 99: 10276-10281.
102. Horvath RJ, Romero-Sandoval EA, De Leo JA (2010b) Inhibition of microglial P2X4 receptors attenuates morphine tolerance, Iba1, GFAP and m opioid receptor protein expression while enhancing perivascular microglial ED2. Pain 150: 401-413.
103. Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, et al. (2008) Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun 22: 1178-1189.
104. Cahill CM, Holdridge SV, Morinville A (2007) Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28: 23-31. (Pubitemid 46049831)
105. Bie B, Pan ZZ (2007) Trafficking of central opioid receptors and descending pain inhibition. Mol Pain 3: 37.
106. Zhang X, Bao L, Guan JS (2006) Role of delivery and trafficking of delta-opioid peptide receptors in opioid analgesia and tolerance. Trends Pharmacol Sci. 27:324-329. (Pubitemid 44183608)
107. Pradhan AA, Befort K, Nozaki C, Gavériaux-Ruff C, Kieffer BL (2011) The delta opioid receptor: anevolving target for the treatment of braindisorders. Trends Pharmacol Sci 32: 581-590.
108. Clinicaltrials website. Available: http://clinicaltrials.gov/ct2/results? term=delta+opioid&Search=Search. Accessed 2014 May 20.